查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375481

生物製藥生物分離系統市場：按類型、最終用戶分類 - 全球預測 2023-2030 年

Biopharmaceutical Bioseparation Systems Market by Type (Cell Disruption Technology, Centrifuges Technology, Chromatography Technique), End-user (Biopharmaceutical Companies, Research Institutes) - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

生物製藥生物分離系統市場預計將從 2022 年的 138.5 億美元增加到 2030 年的 284.9 億美元，預測期內年複合成長率為 9.42%。

生物製藥生物分離系統的全球市場

主要市場統計
市場金額：基準年 [2022] 138.5億美元
預計市場價值 [2023] 151億美元
預計市場量[2030] 284.9億美元
年複合成長率（%） 9.42%
生物製藥生物分離系統市場-IMG1

FPNV定位矩陣

FPNV定位矩陣是評估生物製藥生物分離系統市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。這個富有洞察力的框架使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧洞察。

本報告解決了以下關鍵問題：

1.生物製藥生物分離系統市場的市場規模與預測為何？

2. 生物製藥生物分離系統市場中哪些產品、細分市場、應用和領域具有最高投資潛力？

3.生物製藥生物分離系統市場的競爭策略視窗有哪些？

4.生物製藥生物分離系統市場的最新技術趨勢和法律規範是什麼？

5.生物製藥生物分離系統市場主要供應商的市場佔有率是多少？

6. 進入生物製藥生物分離系統市場的合適型態和策略性手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 對生物製藥和個人化醫療的需求不斷成長
      • 政府支持國內醫藥產業的配合措施
      • 標靶治療的日益普及和重要性
    • 抑制因素
      • 生物分離設備初期投資運作成本較高
    • 機會
      • 擴大對生物分離公司和技術的投資
      • 生物製藥分離技術的進展
    • 任務
      • 法規挑戰和複雜的檢驗流程
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 生物製藥生物分離系統市場：依類型

  • 細胞破壞技術
  • 離心機技術
  • 色譜技術
  • 電泳
  • 萃取技術
  • 過濾技術
  • 基於膜的
  • 沉澱

第7章 生物製藥生物分離系統市場：依最終用戶分類

  • 生物製藥公司
  • 調查機構

第8章 美洲生物製藥生物分離系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區生物製藥生物分離系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲生物製藥生物分離系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情境分析：主要企業

第12章競爭產品組合

  • 主要企業簡介
    • 3M Company
    • Agilent Technologies, Inc.
    • Alfa Wassermann, Inc.
    • Asahi Kasei Medical Co., Ltd.
    • Astrea Bioseparations Limited
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Flottweg SE
    • GEA Group Aktiengesellschaft
    • GL Sciences Inc.
    • Hitachi High-Tech Corporation.
    • Jasco Pty Ltd.
    • KNAUER Wissenschaftliche Gerate GmbH
    • Merck KGaA
    • Novasep Holding SAS
    • PerkinElmer Inc.
    • Repligen Corporation
    • Restek Corporation
    • Sartorius AG
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Tosoh Bioscience LLC
    • Waters Corporation
    • YMC Co., Ltd.
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-521BAA36EA9C

The Biopharmaceutical Bioseparation Systems Market is projected to reach USD 28.49 billion by 2030 from USD 13.85 billion in 2022, at a CAGR of 9.42% during the forecast period.

Global Biopharmaceutical Bioseparation Systems Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 13.85 billion
Estimated Year Value [2023] USD 15.10 billion
Forecast Year Value [2030] USD 28.49 billion
CAGR (%) 9.42%
Biopharmaceutical Bioseparation Systems Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biopharmaceutical Bioseparation Systems Market.

Based on Type, market is studied across Cell Disruption Technology, Centrifuges Technology, Chromatography Technique, Electrophoresis, Extraction Technique, Filtration Technology, Membrane-based, and Precipitation. The Electrophoresis is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Biopharmaceutical Companies and Research Institutes. The Biopharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biopharmaceutical Bioseparation Systems Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biopharmaceutical Bioseparation Systems Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biopharmaceutical Bioseparation Systems Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Alfa Wassermann, Inc., Asahi Kasei Medical Co., Ltd., Astrea Bioseparations Limited, Bio-Rad Laboratories, Inc., Danaher Corporation, Flottweg SE, GEA Group Aktiengesellschaft, GL Sciences Inc., Hitachi High-Tech Corporation., Jasco Pty Ltd., KNAUER Wissenschaftliche Gerate GmbH, Merck KGaA, Novasep Holding SAS, PerkinElmer Inc., Repligen Corporation, Restek Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Bioscience LLC, Waters Corporation, and YMC Co., Ltd..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Biopharmaceutical Bioseparation Systems Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Biopharmaceutical Bioseparation Systems Market?

3. What is the competitive strategic window for identifying opportunities in the Biopharmaceutical Bioseparation Systems Market?

4. What are the latest technology trends and regulatory frameworks in the Biopharmaceutical Bioseparation Systems Market?

5. What is the market share of the leading vendors in the Biopharmaceutical Bioseparation Systems Market?

6. Which modes and strategic moves are suitable for entering the Biopharmaceutical Bioseparation Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biopharmaceutical Bioseparation Systems Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for biopharmaceuticals and personalized medicines
      • 5.1.1.2. Government initiatives to boost domestic pharmaceutical industry
      • 5.1.1.3. Growing popularity and importance of targeted therapies
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investments and operating costs of bioseparation equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing investments in bioseparation companies and technologies
      • 5.1.3.2. Rising advancements in biopharmaceutical separation technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory challenges and complex validation processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Biopharmaceutical Bioseparation Systems Market, by Type

  • 6.1. Introduction
  • 6.2. Cell Disruption Technology
  • 6.3. Centrifuges Technology
  • 6.4. Chromatography Technique
  • 6.5. Electrophoresis
  • 6.6. Extraction Technique
  • 6.7. Filtration Technology
  • 6.8. Membrane-based
  • 6.9. Precipitation

7. Biopharmaceutical Bioseparation Systems Market, by End-user

  • 7.1. Introduction
  • 7.2. Biopharmaceutical Companies
  • 7.3. Research Institutes

8. Americas Biopharmaceutical Bioseparation Systems Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biopharmaceutical Bioseparation Systems Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Bioseparation Systems Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. 3M Company
    • 12.1.2. Agilent Technologies, Inc.
    • 12.1.3. Alfa Wassermann, Inc.
    • 12.1.4. Asahi Kasei Medical Co., Ltd.
    • 12.1.5. Astrea Bioseparations Limited
    • 12.1.6. Bio-Rad Laboratories, Inc.
    • 12.1.7. Danaher Corporation
    • 12.1.8. Flottweg SE
    • 12.1.9. GEA Group Aktiengesellschaft
    • 12.1.10. GL Sciences Inc.
    • 12.1.11. Hitachi High-Tech Corporation.
    • 12.1.12. Jasco Pty Ltd.
    • 12.1.13. KNAUER Wissenschaftliche Gerate GmbH
    • 12.1.14. Merck KGaA
    • 12.1.15. Novasep Holding SAS
    • 12.1.16. PerkinElmer Inc.
    • 12.1.17. Repligen Corporation
    • 12.1.18. Restek Corporation
    • 12.1.19. Sartorius AG
    • 12.1.20. Shimadzu Corporation
    • 12.1.21. Thermo Fisher Scientific Inc.
    • 12.1.22. Tosoh Bioscience LLC
    • 12.1.23. Waters Corporation
    • 12.1.24. YMC Co., Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET DYNAMICS
  • FIGURE 7. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 10. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 12. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 14. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 20. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL DISRUPTION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGES TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY EXTRACTION TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY FILTRATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 104. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 105. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET LICENSE & PRICING